Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 5.65%

Amedisys, Inc. EBIT Margin is 5.65% for the Trailing 12 Months (TTM) ending June 30, 2025, a -35.29% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 8.73%, a 161.50% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 3.34%, a -63.66% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 9.18%, a -30.48% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 13.21%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin